Despite significant therapy-induced changes in specific uptake of [64Cu]Cu-NOTA-α-CXCR3 in the spleen and lymph nodes, limitations were encountered with respect to imaging changes in CXCR3+ T cell infiltration or CXCR3 upregulation on tumor-resident T cells. Here, CXCR3 is linked to neoplasm.